All the resolutions approved by the Board of Directors were adopted
Shefali Agarwal, Chairman and Chief Executive Officer, declares: “I would like to thank all of our shareholders for their participation and their support during this General Meeting which marks a real turning point for our Company. We are proud to present to you today our new corporate name, conveying values of strength, health, resilience, vitality and robustness. In addition, the Valerio name has a timeless and traditional essence that responds to the positioning of a clinical-stage biotechnology company that focuses on the development of innovative therapies using cutting-edge technology platforms to revolutionize cancer treatment and improve outcomes. for patients. Valerio also represents the meaning of heritage and endurance, thus becoming part of Onxeo’s history to write a new page over time. »
To receive all of ONXEO’s financial information in real time, send a request by email to [email protected]. Your registration will be immediate.